BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32133625)

  • 1. Highlights into the pharmacology of nutraceuticals.
    Andrew R; Izzo AA
    Br J Pharmacol; 2020 Mar; 177(6):1209-1211. PubMed ID: 32133625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals.
    Williamson EM; Liu X; Izzo AA
    Br J Pharmacol; 2020 Mar; 177(6):1227-1240. PubMed ID: 31799702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of pharmacological research of nutraceuticals.
    Andrew R; Izzo AA
    Br J Pharmacol; 2017 Jun; 174(11):1177-1194. PubMed ID: 28500635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutraceuticals as modulators of gut microbiota: Role in therapy.
    Quigley EMM
    Br J Pharmacol; 2020 Mar; 177(6):1351-1362. PubMed ID: 31659751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing.
    Howes MR; Perry NSL; Vásquez-Londoño C; Perry EK
    Br J Pharmacol; 2020 Mar; 177(6):1294-1315. PubMed ID: 31650528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of gut microbiota and circadian rhythm in the cardiovascular protective effects of polyphenols.
    Man AWC; Xia N; Daiber A; Li H
    Br J Pharmacol; 2020 Mar; 177(6):1278-1293. PubMed ID: 31465555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence.
    Lin SR; Chang CH; Hsu CF; Tsai MJ; Cheng H; Leong MK; Sung PJ; Chen JC; Weng CF
    Br J Pharmacol; 2020 Mar; 177(6):1409-1423. PubMed ID: 31368509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota-dependent and -independent effects of dietary fibre on human health.
    Cai Y; Folkerts J; Folkerts G; Maurer M; Braber S
    Br J Pharmacol; 2020 Mar; 177(6):1363-1381. PubMed ID: 31663129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary antioxidants remodel DNA methylation patterns in chronic disease.
    Beetch M; Harandi-Zadeh S; Shen K; Lubecka K; Kitts DD; O'Hagan HM; Stefanska B
    Br J Pharmacol; 2020 Mar; 177(6):1382-1408. PubMed ID: 31626338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological basis and new insights of resveratrol action in the cardiovascular system.
    Cheng CK; Luo JY; Lau CW; Chen ZY; Tian XY; Huang Y
    Br J Pharmacol; 2020 Mar; 177(6):1258-1277. PubMed ID: 31347157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From primordial gas to the medicine cabinet.
    Papapetropoulos A; Wallace JL; Wang R
    Br J Pharmacol; 2020 Feb; 177(4):715-719. PubMed ID: 31726475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the development and exploitation of new therapeutic options targeting the histaminergic system.
    Chazot PL; Tiligada E
    Br J Pharmacol; 2020 Feb; 177(3):467-468. PubMed ID: 31994717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial for GPR84 pharmacology.
    Milligan G
    Br J Pharmacol; 2024 May; 181(10):1497-1499. PubMed ID: 38456201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of sex differences in pharmacology research.
    Gogos A; Langmead C; Sullivan JC; Lawrence AJ
    Br J Pharmacol; 2019 Nov; 176(21):4087-4089. PubMed ID: 31769019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting inflammation to reduce cardiovascular disease risk.
    Maffia P; Cirino G
    Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pharmacology of GPCRs.
    Langmead CJ; Summers RJ
    Br J Pharmacol; 2018 Nov; 175(21):4005-4008. PubMed ID: 30302756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of cognition: a panacea for neuropsychiatric disease?
    Bailey SJ; Neill JC; Moran PM
    Br J Pharmacol; 2017 Oct; 174(19):3133-3135. PubMed ID: 28901012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When pharmacology meets the microbiome: new targets for therapeutics?
    Hyland NP; Cryan JF
    Br J Pharmacol; 2018 Dec; 175(24):4401-4403. PubMed ID: 30478976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary fat and obesity as modulators of breast cancer risk: Focus on DNA methylation.
    Donovan MG; Wren SN; Cenker M; Selmin OI; Romagnolo DF
    Br J Pharmacol; 2020 Mar; 177(6):1331-1350. PubMed ID: 31691272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pharmacology of G protein-coupled receptors.
    Summers RJ
    Br J Pharmacol; 2016 Oct; 173(20):2931-3. PubMed ID: 27682321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.